Handelsbanken Fonder Ab Amylyx Pharmaceuticals, Inc. Transaction History

Handelsbanken Fonder Ab

  • $25.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$2.71 - $19.57 $7,588 - $54,796
2,800 Added 23.53%
14,700 $42,000
Q4 2023

Feb 01, 2024
BUY
$12.07 - $18.46 $143,633 - $219,674
11,900 New
11,900 $175,000
Q4 2022

Feb 07, 2023
BUY
$29.75 - $39.26 $181,475 - $239,486
6,100 New
6,100 $225,000

Others Institutions Holding AMLX

# of Institutions
139
Shares Held
46.5M
Call Options Held
226K
Put Options Held
909K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email